SCHEMBL353378

SCHEMBL353378

NC(=O)c1cccc2cc(-c3ccc4c(C(=O)N(CCc5ccccc5)CCc5ccccc5)cccc4c3)ccc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F10 P00742 6/20 0.48
F7 P08709 6/20 0.48
F2 P00734 5/20 0.48
KDM4E B2RXH2 2/20 0.47
ALDH1A1 P00352 1/20 0.47
GAA P10253 1/20 0.47
KMT2A Q03164 3/20 0.41
SCN5A Q14524 1/20 0.41
SCN2A Q99250 1/20 0.41
MEN1 O00255 2/20 0.40
PARP1 P09874 2/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
HDAC1 Q13547 2/20 0.39
HDAC6 Q9UBN7 2/20 0.39
HDAC3 O15379 1/20 0.39
HDAC4 P56524 1/20 0.39
HDAC7 Q8WUI4 1/20 0.39
HDAC2 Q92769 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL352442 0.89 F2 (0.42) F10F7F2KDM4EALDH1A1
SCHEMBL634882 0.80 KDM4E (0.65) KDM4EALDH1A1GAAPARP1
SCHEMBL353654 0.79 HSD17B2 (0.43) F10F7F2KDM4EALDH1A1
SCHEMBL353489 0.78 ALDH1A1 (0.53) KDM4EALDH1A1GAAPARP1
SCHEMBL241944 0.78 KDM4E (0.44) F10F7F2KDM4EALDH1A1
SCHEMBL634716 0.76 KDM4E (0.53) KDM4EALDH1A1GAAKMT2AMEN1
SCHEMBL355056 0.75 HSD17B1 (0.43) F10F7F2KDM4EALDH1A1
SCHEMBL355595 0.73 TRPM8 (0.46) KDM4EALDH1A1GAAPARP1RPS6KB1
SCHEMBL353582 0.71 KDM4E (0.48) KDM4EALDH1A1GAAPARP1
SCHEMBL4066112 0.71 TP53 (0.55) KDM4EALDH1A1KMT2AMEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120015992-A1 Napthalene-Based Inhibitors of Anti-Apoptotic Proteins BURNHAM INSTITUTE FOR MEDICAL RESEARCH (US) 2012-01-19 US disclosed
US-8039668-B2 Naphthalene-based inhibitors of anti-apoptotic proteins BURNHAM INSTITUTE FOR MEDICAL RESEARCH (US) 2011-10-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120015992-A1 Napthalene-Based Inhibitors of Anti-Apoptotic Proteins HAX1, PRDX1, APOL1 F10 937/4885F7 4344/4885F2 3989/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.